Elisa Cappuzzello

Elisa Cappuzzello

UNVERIFIED PROFILE

Are you Elisa Cappuzzello?   Register this Author

Register author
Elisa Cappuzzello

Elisa Cappuzzello

Publications by authors named "Elisa Cappuzzello"

Are you Elisa Cappuzzello?   Register this Author

7Publications

302Reads

45Profile Views

Fc Glyco- and Fc Protein-Engineering: Design of Antibody Variants with Improved ADCC and CDC Activity.

Methods Mol Biol 2018 ;1827:381-397

Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, University Hospital Schleswig-Holstein and Christian-Albrechts, University of Kiel, Kiel, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-1-4939-8648-4_20
Publisher Site
http://dx.doi.org/10.1007/978-1-4939-8648-4_20DOI Listing
April 2019

Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy.

Transfus Med Hemother 2017 Sep 8;44(5):327-336. Epub 2017 Sep 8.

Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel, Kiel, Germany.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/479980
Publisher Site
http://dx.doi.org/10.1159/000479980DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649276PMC
September 2017

Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells.

Cytokine Growth Factor Rev 2017 08 3;36:99-105. Epub 2017 Jun 3.

Department of Surgery, Oncology and Gastroenterology, Oncology and Immunology Section, University of Padua, Padua, Italy; Department of Clinical and Experimental Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cytogfr.2017.06.003DOI Listing
August 2017

Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies.

Oncoimmunology 2016 Aug 30;5(8):e1199311. Epub 2016 Jun 30.

Department of Surgery, Oncology and Gastroenterology, Oncology and Immunology Section, University of Padova, Padua, Italy; Department of Clinical and Experimental Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1199311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007963PMC
August 2016